Medical MCQ
MCQ Ebook
Biochemistry
Microbiology
Pathology
MCQ Subjects
Anaesthesia
Anatomy
Biochemistry
Dental
ENT
Forensic Medicine
Gynaecology & Obstetrics
Medicine
Microbiology
Ophthalmology
Orthopaedics
Pathology
Pediatrics
Pharmacology
Physiology
Psychiatry
Radiology
Skin
Social & Preventive Medicine
Surgery
Others
MCQ Exam
Anaesthesia
Anatomy
Biochemistry
Dental
ENT
Forensic Medicine
Gynaecology & Obstetrics
Medicine
Microbiology
Ophthalmology
Orthopaedics
Pathology
Pediatrics
Pharmacology
Physiology
Psychiatry
Radiology
Skin
Social & Preventive Medicine
Surgery
Others
All MCQs
Term Of Use
Privacy Policy
Contact Us
About Us
Home
Ebooks
Questions
Search
Pharmacology
Recently a new oral drug is approved for treatment of multiple myeloma. It acts as a selective inhibitor of nuclear expo. Which drug is it ?
SELINEXOR
POLATUZUMAB
ZANUBRUTINIB
FEDRATINIB
Questions
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100